Each year we recognise Professor Walsh for his contribution to research, innovation and as a pioneer in the treatment and diagnosis of prostate cancer. Professor Tony Costello and Professor Patrick Walsh will introduce this year's recipient - Professor Leonard Gomella .
Professor Leonard Gomella, the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at the Sidney Kimmel Medical College and Senior Director for Clinical Affairs for the Sidney Kimmel Cancer Center at Jefferson. Prof Gomella is involved in translational research in the development of new diagnostic techniques and treatments for prostate cancer. His team was first use molecular techniques to detect circulating tumor cells in prostate cancer in 1992 and has been co-chair of the first two international conferences on genetic testing for prostate cancer in 2017 and 2019. He is Urology Chair for NRG (RTOG) and past president of the Society of Urologic Oncology and Editor-in-Chief, Canadian Journal of Urology International.
With almost 1 million new cases per year, prostate cancer is the most prevalent malignancy in men worldwide and causes about 300,000 deaths annually. In recent years, large-scale genomic sequencing projects have catalogued common genomic alterations, which enabled an improved molecular classification of prostate tumours and led to a better understanding of the molecular mechanisms driving the initiation and progression of the disease. In this session we will hear from world leaders in genomics.